Bahiafarma | Fundação Baiana de Pesquisa, Desenvolvimento, Fornecimento e Distrib. de Medicamentos

What Bahiafarma | Fundação Baiana de Pesquisa, Desenvolvimento, Fornecimento e Distrib. de Medicamentos does

Bahiafarma — formally Fundação Baiana de Pesquisa, Desenvolvimento, Fornecimento e Distribuição de Medicamentos — is a state pharmaceutical foundation established in 2011 and headquartered in Simões Filho, Bahia, Brazil. It is owned and controlled by the Government of the State of Bahia and operates as a non-profit public-sector entity within the Brazilian pharmaceutical value chain.

The foundation's core activity is the manufacture and distribution of medications prioritized for the Brazilian public health system, most notably Insulina Humana NPH — a strategic biologic — alongside a portfolio of generic and other strategic medications. Distribution flows directly into SUS (Sistema Único de Saúde) channels, with the State of Bahia functioning as both owner and anchor customer. The entity maintains an in-house technology transfer office, NIT Bahiafarma, and a dedicated Parcerias (Partnerships) function, signaling formal engagement with R&D and supply-chain counterparties beyond pure in-house manufacturing.

The business model is government-anchored rather than commercial: Bahiafarma is funded through state appropriations and procurement contracts, sells into public-sector channels rather than private pharmacies, and operates under a non-profit mandate aligned with Bahia's health policy objectives. With 92 employees, the foundation functions as a small, mission-specific manufacturer whose growth and product roadmap are dictated by state and federal public-health priorities rather than market competition.

Name

Bahiafarma | Fundação Baiana de Pesquisa, Desenvolvimento, Fornecimento e Distrib. de Medicamentos

Legal name

Fundação Baiana de Pesquisa Científica e Desenvolvimento Tecnológico, Fornecimento e Distribuição de Medicamentos

Website

https://bahiafarma.ba.gov.br

Company type

Private

Operating status

Operating

Short description

Bahiafarma is a Bahia state-owned pharmaceutical foundation that manufactures and distributes generic and strategic medications, most notably Insulina Humana NPH, directly into the Brazilian public health system (SUS) and state health channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Executive, Legislative, and Other General Government Support (9211)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)

akta.pro secondary industries

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Public Health Policy, Planning & Governance (BPAIAJAB)

Keywords

• Generic medications
• Public health supply
• Drug development
• Pharmaceutical manufacturing
• Insulin production

Headquarters

HQ city

Simões Filho

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels1 record

Core offering

Bahiafarma is a state government foundation that conducts scientific research, develops, manufactures, and distributes essential pharmaceutical products—including its flagship Insulina Humana NPH and a portfolio of generic and strategic medications—for the public health system (SUS) of the State of Bahia. Its portfolio is centered on essential medicines supplied to public healthcare facilities and pharmacies, reducing Bahia's dependence on private pharmaceutical suppliers.

Product overview

Bahiafarma is a Bahia State government foundation dedicated to scientific research, technological development, supply, and distribution of medications. The organization operates through multiple directorates including General, Administrative-Financial, Operations, Research and Development, and Quality. The product portfolio centers on essential and strategic medications, with notable focus on human insulin NPH products, distributed to public healthcare facilities across Bahia state.

Differentiator

Problem solved

Functional benefit

Products and services

• Bahiafarma Insulina Humana NPH

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Market position

Competitive moat3 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bahiafarma | Fundação Baiana de Pesquisa, Desenvolvimento, Fornecimento e Distrib. de Medicamentos